John C. Lechleiter
2014
In 2014, John C. Lechleiter earned a total compensation of $14.5M as Chairman, President, and Chief Executive Officer at Lilly Eli & Co, a 29% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $4,356,142 |
|---|---|
| Non-Equity Incentive Plan | $1,785,000 |
| Salary | $1,500,000 |
| Stock Awards | $6,750,000 |
| Other | $90,000 |
| Total | $14,481,142 |
Lechleiter received $6.8M in stock awards, accounting for 47% of the total pay in 2014.
Lechleiter also received $4.4M of change in pension value and nonqualified deferred compensation earnings, $1.8M in non-equity incentive plan, $1.5M in salary and $90K in other compensation.
Rankings
In 2014, John C. Lechleiter's compensation ranked 255th out of 13,032 executives tracked by ExecPay. In other words, Lechleiter earned more than 98.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 255 out of 13,032 | 98th |
Division Manufacturing | 99 out of 4,966 | 98th |
Major group Chemicals And Allied Products | 37 out of 1,686 | 98th |
Industry group Drugs | 29 out of 1,365 | 98th |
Industry Pharmaceutical Preparations | 27 out of 1,043 | 97th |
Source: SEC filing on March 20, 2017.
Lechleiter's colleagues
We found four more compensation records of executives who worked with John C. Lechleiter at Lilly Eli & Co in 2014.
2014
Derica Rice
Lilly Eli & Co
Chief Financial Officer
2014
Jan Lundberg
Lilly Eli & Co
Executive Vice President, Science and Technology, and President, Lilly Research Laboratories
2014
Michael Harrington
Lilly Eli & Co
General Counsel
2014
Enrique Conterno
Lilly Eli & Co